Biotech entity
Every one of those 1 sits in a single category, clinical-trial. Stanford University is most often covered alongside FDA, which appears in 1 of these 1 story. Stanford University appears in 1 tracked Biotech story from February 20, 2026. The tracked stories average 2 original sources each.
Last mentioned: Jul 15, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, clinical-trial. Stanford University is most often covered alongside FDA, which appears in 1 of these 1 story. Stanford University appears in 1 tracked Biotech story from February 20, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Stanford University. Shared-story counts are live from our verified record — not editorial picks.
Phase I Trials
Anticipated start of first-in-human safety and dosage escalation studies.
IND Filing
Target window for filing an Investigational New Drug application with the FDA.
Pre-clinical Completion
Expected conclusion of animal model testing and toxicology reports.
Study Publication
Stanford University researchers publish findings on a multi-pathogen vaccine candidate.
Researchers at Stanford University have unveiled a novel vaccine candidate designed to provide broad-spectrum protection against a variety of viral infections. This multi-pathogen approach marks a significant shift from traditional strain-specific immunizations toward a more resilient public health defense.
Source: mercurynews.com · claycord.com
Stanford University is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
